191 – 200 of 206
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Cerebrospinal fluid inflammatory markers in Parkinson's disease - Associations with depression, fatigue, and cognitive impairment.
(
- Contribution to journal › Article
-
Mark
Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies.
(
- Contribution to journal › Article
-
Mark
Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: The EPIC cohort.
(
- Contribution to journal › Article
-
Mark
Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters.
(
- Contribution to journal › Article
-
Mark
Serum but not Cerebrospinal Fluid levels of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 (IGFBP-3) are Increased in Alzheimer ́s Disease
2013) Endokrindagarna, 2013(
- Contribution to conference › Poster
-
Mark
Future falls and/or near falls in people with Parkinson’s disease: Sensitivity and specificity of two retropulsion tests
2013) International Congress of Parkinson's Disease and Movement Disorders, 2013 In Movement Disorders 28(S1). p.163-163(
- Contribution to journal › Published meeting abstract
-
Mark
ROI-based analysis of diffusional kurtosis estimates for identification of MCI-patients at high risk for conversion to Alzheimer’s disease in a heterogeneous MCI cohort
2013) ISMRM, 2013(
- Contribution to conference › Poster
- 2012
-
Mark
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
(
- Contribution to journal › Article
-
Mark
CSF Biomarkers Correlate with Cerebral Blood Flow on SPECT in Healthy Elderly.
(
- Contribution to journal › Article
-
Mark
Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serum.
(
- Contribution to journal › Article